The Market Fieldbook

Confirming your account

Your account is being prepared. You will be redirected securely in a moment.

Company Observatory

MMSI

Merit Medical Systems, Inc.

Healthcare · Medical - Instruments & Supplies

Overall research band Mixed
Quality Mixed
Valuation Mixed
Balance sheet Very weak
Market confirmation Exceptional

One-minute company read

What this report can tell you now

What the company does

Merit Medical Systems, Inc. designs, develops, manufactures, and commercializes disposable medical products used in diagnostic, therapeutic, and interventional procedures across cardiology, radiology, oncology, critical care, and endoscopy. Operating through Cardiovascular and Endoscopy divisions, the company offers products such as vascular access tools, angiography and electrophysiology devices, cardiac rhythm management solutions, fluid and hemodynamic monitoring systems, hemostasis products, MEMS sensor components, pulmonary stents, dilation balloons, and a range of kits and accessories for endoscopy and bronchoscopy. Merit Medical serves hospitals and healthcare professionals—including physicians, technicians, and nurses—in both traditional and alternative care settings, distributing its products via a direct sales force, authorized distributors, OEM partnerships, and custom tray manufacturers in the United States and internationally. The company generates revenue by selling its medical devices and procedural solutions to these customers.

The current research profile is Mixed Setup, with elevated leverage. This is a starting point for investigation, not a forecast or recommendation.

Strongest visible signal

Recent market behavior is the strongest visible confirmation. Check whether it agrees with the underlying business evidence.

What to investigate next

Read the latest filing or company update, check the period behind the metrics, and investigate the dimension with the weakest band above.

Before you draw a conclusion

  • Read the latest filing or company update.
  • Check the financial period behind each metric.
  • Investigate the weakest score band and any missing evidence.

Headline fundamentals

A small set of signals worth checking

ROIC7.2%Model input; read with the evidence status and period context.
Operating margin12.2%Model input; read with the evidence status and period context.
Revenue CAGR · 4 years9.0%Model input; read with the evidence status and period context.
FCF margin14.0%Model input; read with the evidence status and period context.

Go deeper when you need to

Compare the right companies, understand what changed, and monitor the evidence.

Peer contextCompare companies using the appropriate economic neighborhood.
Evidence detailSee exact inputs, source context, and model-aware metrics.
HistoryReview score and research changes over time.
MonitoringKeep the questions, risks, and changes that matter in view.

The public report remains useful on its own. Premium adds depth, history, comparison, and monitoring.